Project Grant R21CA318443
Award Date 7/20/26
Completion Date 6/30/28
Dollars Obligated $427K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute (NCI), under the Cancer Biology Research program (CFDA 93.396), awarded a $401,115 Project Grant to the University of Texas Health Science Center at Houston for a two-year research initiative spanning August 1, 2026, through July 31, 2028. The award supports fundamental research investigating the molecular mechanisms by which hepatic Sirtuin 3 (SIRT3) regulates the progression from metabolic dysfunction-associated steatohepatitis (MASH)...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $2.88 million Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), effective August 5, 2025, through July 31, 2029. This award supports the development of etiology-adjusted precision liver cancer risk prediction tools and resources. The project focuses on developing non-invasive biomarkers and risk assessment strategies...
- Federal Project Grant Award Summary The National Cancer Institute awarded The University of Texas Southwestern Medical Center a $682,969 Project Grant under the Cancer Biology Research program (CFDA 93.396) for the period July 1, 2026 through June 30, 2031. The project, titled "Hormonal Regulation of Myeloid Checkpoints in the Tumor Microenvironment," will deliver fundamental cancer immunology research focused on understanding how hormonal signaling regulates immunosuppressive...
- Federal Project Grant Award Summary The University of Texas MD Anderson Cancer Center received a $421,685 project grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), awarded August 1, 2025, with a completion date of July 31, 2027. This award supports research investigating the LIFR-LCN2 pathway as a novel mechanism of immune suppression in hepatocellular carcinoma (HCC). The research aims to elucidate how loss of LIFR upregulates LCN2, leading to...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $621,121 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), awarded July 10, 2026, with completion scheduled for June 30, 2031. This grant funds fundamental cancer biology research investigating tumor-niche co-evolution mechanisms driving metastatic ovarian cancer (MOVCA) progression and therapeutic resistance. The research integrates...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $402,011 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396) for a five-year research project running from May 1, 2026, through April 30, 2031. The award funds fundamental research investigating the KEAP1-NRF2 (Kelch-like ECH-associated protein 1-Nuclear Factor Erythroid 2-Related Factor 2) redox-sensing pathway and its role in controlling T-cell...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The University of Texas Southwestern Medical Center a $498,732 Project Grant under the Cancer Treatment Research program (CFDA 93.395) effective July 1, 2026, through June 30, 2031. This research initiative will investigate the role of low-density lipoprotein (LDL) uptake in tumor immunity and immunotherapy efficacy, specifically examining how systemic and tumor-local LDL availability influences CD8+ T cell function and...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $687,594 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396) effective July 1, 2026, through June 30, 2031. The award supports fundamental research investigating brain metastasis organotropism and therapy response in small cell lung cancer (SCLC). The project delivers preclinical research services including development and...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Texas at Austin a $626,203 Project Grant on July 16, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to investigate the mechanisms linking obesity to prostate cancer progression through DNA structure-induced genetic instability. The research will be conducted through June 30, 2031, and focuses on elucidating how obesity increases mutagenesis at H-DNA sequences—alternative DNA...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $7.54 million Cancer Centers Support Grant (CCSG, CFDA 93.397) from the National Cancer Institute, awarded September 5, 2025, through August 31, 2030. This grant supports the UT Southwestern Liver Cancer Specialized Program of Research Excellence (SPORE), which assembles a multidisciplinary team of basic, clinical, and translational scientists to develop personalized medical interventions targeting...